Ezra M. Friedberg - 21 Feb 2024 Form 4/A Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Ezra Friedberg
Issuer symbol
CHRO
Transactions as of
21 Feb 2024
Net transactions value
+$100,002
Form type
4/A
Filing time
12 Mar 2024, 16:05:51 UTC
Date Of Original Report
21 Feb 2024
Previous filing
15 Feb 2024
Next filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRO Common Stock Purchase $100,002 +16,667 +3.2% $6.00* 545,721 21 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.